During the past decade, HammondCare Aged Psychiatry Clinical Trials conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "HammondCare Aged Psychiatry Clinical Trials" are "Alzheimer Disease" (1 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "HammondCare Aged Psychiatry Clinical Trials" in a lesser frequency.

Most popular intervention types in "HammondCare Aged Psychiatry Clinical Trials" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Gantenerumab" (1 trials), "Semorinemab" (1 trials) and "[18F]GTP1" (1 trials). Other intervention names were less common.

The vast majority of trials in "HammondCare Aged Psychiatry Clinical Trials" are 2 trials for "All" genders.

Currently, there are NaN active trials in "HammondCare Aged Psychiatry Clinical Trials". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in HammondCare Aged Psychiatry Clinical Trials, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in HammondCare Aged Psychiatry Clinical Trials, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".